syringic acid has been researched along with Blood Pressure, High in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alajarín, R; Alvarez-Builla, J; Díez-Marqués, ML; García, G; Griera, M; Rodríguez-Puyol, D; Rodríguez-Puyol, M; Sánchez-Alonso, P; Serrano, I; Vaquero, JJ | 1 |
| Chadha, R; Haneef, J | 1 |
| Kumar, S; Prahalathan, P; Raja, B | 1 |
3 other study(ies) available for syringic acid and Blood Pressure, High
| Article | Year |
|---|---|
New losartan-hydrocaffeic acid hybrids as antihypertensive-antioxidant dual drugs: Ester, amide and amine linkers.
Topics: Amides; Amines; Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Aorta, Thoracic; Caffeic Acids; Cells, Cultured; Esters; Hypertension; Losartan; Male; Molecular Structure; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Structure-Activity Relationship; Vasoconstrictor Agents | 2012 |
Antioxidant-Based Eutectics of Irbesartan: Viable Multicomponent Forms for the Management of Hypertension.
Topics: Animals; Antihypertensive Agents; Antioxidants; Ascorbic Acid; Biphenyl Compounds; Calorimetry, Differential Scanning; Gallic Acid; Hydrogen Peroxide; Hypertension; Irbesartan; Kidney; Male; Niacin; Rats; Solubility; Tetrazoles | 2018 |
Syringic acid ameliorates (L)-NAME-induced hypertension by reducing oxidative stress.
Topics: Animals; Antioxidants; Biomarkers; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Gallic Acid; Hypertension; Kidney Function Tests; Lipid Peroxidation; Liver Function Tests; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar | 2012 |